4
Changes in Ownership
Humacyte, Inc. Filed Acc 0001104659-23-065547
Chief Operating Officer sold 23,402 shares at an average $4.01 ($93,904)
- Chief Operating Officer acquired 78,779 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Prichard Heather Ledbetter · Chief Operating Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-24 | Exercise or conversion : show line 1 in the form | +13,789 | $1.19 | $16,409 | 22,978 | D |
| 2023-05-24 | Sale : show line 2 in the form | −13,789 | $4.14 | $57,086 | 9,189 | D |
| 2023-05-25 | Exercise or conversion : show line 3 in the form | +64,990 | $1.19 | $77,338 | 74,179 | D |
| 2023-05-25 | Sale : show line 4 in the form | −9,613 | $3.83 | $36,818 | 64,566 | D |
| Open-market sales · 23,402 sh · avg $4.01 · $93,904 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-05-24 | Exercise or conversion : show line 5 in the form Stock Options (right to buy) | −13,789 | 64,990 | D |
| 2023-05-25 | Exercise or conversion : show line 6 in the form Stock Options (right to buy) | −64,990 | 0 | D |
Loading xslF345X04/tm2317123-10_4seq1.xml…